Mechanistic description
Transient Aβ exposure induces dendritic tau missorting that then converts into a locally self-propagating tau oligomer/seeding program. After verified Aβ clearance, continued degeneration is driven by tau seed formation, templated misfolding, and trans-synaptic spread rather than by ongoing amyloid signaling.
Mechanism / pathway
- MAPT
- neurodegeneration
Evidence for (8)
Tau oligomer formation and propagation are well supported, making an autonomous post-trigger seeded state biologically plausible.
Aβ can heterotypically seed or accelerate tau propagation, supporting an initiator-to-seeding transition model.
Aβ oligomers induce tau missorting and spine pathology, providing the upstream state from which autonomous seeding could emerge.
MAPT mutations, tauopathy, and mechanisms of neurodegeneration.
Endolysosomal impairment by binding of amyloid beta or MAPT/Tau to V-ATPase and rescue via the HYAL-CD44 axis in Alzheimer disease.
Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.
ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids.
The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes.
Evidence against (2)
Direct proof that transient Aβ exposure alone creates a self-sustaining tau-seeding state after complete Aβ removal remains limited.
Many tau-seeding systems rely on overexpression or persistent pathology, leaving Aβ-independent persistence unresolved.
Evidence matrix
Supporting
- Tau oligomer formation and propagation are well supported, making an autonomous post-trigger seeded state biologically plausible. PMID:23882255
- Aβ can heterotypically seed or accelerate tau propagation, supporting an initiator-to-seeding transition model. PMID:26739002
- Aβ oligomers induce tau missorting and spine pathology, providing the upstream state from which autonomous seeding could emerge. PMID:20826658
- MAPT mutations, tauopathy, and mechanisms of neurodegeneration. PMID:30742061 · 2019 · Lab Invest
- Endolysosomal impairment by binding of amyloid beta or MAPT/Tau to V-ATPase and rescue via the HYAL-CD44 axis in Alzheimer disease. PMID:36843263 · 2023 · Autophagy
- Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial. PMID:37095250 · 2023 · Nat Med
- ELAVL4, splicing, and glutamatergic dysfunction precede neuron loss in MAPT mutation cerebral organoids. PMID:34314701 · 2021 · Cell
- The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes. PMID:38556838 · 2024 · Alzheimers Dement
Contradicting
- Direct proof that transient Aβ exposure alone creates a self-sustaining tau-seeding state after complete Aβ removal remains limited. PMID:26739002
- Many tau-seeding systems rely on overexpression or persistent pathology, leaving Aβ-independent persistence unresolved. PMID:23882255
Bayesian persona consensus
scidex.consensus.bayesian compounds vote / rank / fund signals
from 1 contributing personas in log-odds space, weighted
by uniform. Prior 50%.
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). Tau missorting transitions into an autonomous tau-seeding state after transient…. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-cb692686e2
@misc{scidex_hypothesis_hcb69268,
title = {Tau missorting transitions into an autonomous tau-seeding state after transient…},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-cb692686e2},
note = {SciDEX artifact hypothesis:h-cb692686e2}
}